Benztropine
A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
Year introduced: 1991(1972)
PubMed search builder options
Subheadings:
Tree Number(s): D02.145.074.722.270, D03.132.889.244, D03.605.084.500.722.270, D03.605.869.270
MeSH Unique ID: D001590
Registry Number: 1NHL2J4X8K
Entry Terms:
- Benzatropine
- N-Methylbenztropine
- N Methylbenztropine
- Cogentin
- Benzatropine Methanesulfonate
- Methanesulfonate, Benzatropine
- Benzatropine Mesylate
- Mesylate, Benzatropine
- Benztropine Mesylate
- Mesylate, Benztropine
- Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer
- Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer
- Benzatropine Methanesulfonate, Hydrobromide
- Hydrobromide Benzatropine Methanesulfonate
- Methanesulfonate, Hydrobromide Benzatropine
- Apo-Benztropine
- Apo Benztropine
- Bensylate
- Cogentinol
- PMS-Benztropine
- PMS Benztropine
Previous Indexing:
Pharmacologic Action: